ABIVAX (EPA:ABVX) | Finanzwire

Basculer en Français

9474	Companies
185433	Keywords
117775	Articles
99293	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 10/05/2025 at 17:00, 1 month 30 days ago

Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data
Abivax announces positive results from Phase 3 ABTECT 8-Week Induction Trials on obefazimod for ulcerative colitis treatment with no new safety concerns identified, to present further abstract on October 6

Abivax Obefazimod Ulcerative Colitis Phase 3 Trial Safety Data
BRIEF

published on 10/03/2025 at 11:59, 2 months 1 day ago

JP Morgan Chase & Co. crosses the 5% threshold at ABIVAX

Voting Rights Actions Abivax Threshold Crossing JP Morgan
BRIEF

published on 09/29/2025 at 22:10, 2 months 5 days ago

Abivax Presents New Findings on Obefazimod at UEG 2025

Abivax Obefazimod Ulcerative Colitis Phase 3 Trials UEG Meeting
PRESS RELEASE

published on 09/29/2025 at 22:05, 2 months 5 days ago

Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting
Abivax announces acceptance of additional late-breaking abstract from the ABTECT Phase 3 induction trials to be presented at 2025 United European Gastroenterology (UEG) Meeting

Abivax Ulcerative Colitis Gastroenterology Late-breaking Abstract ABTECT Phase 3
BRIEF

published on 09/23/2025 at 22:10, 2 months 11 days ago

Abivax: Presentation of promising data on obefazimod at the 2025 UEG congress

Abivax Obefazimod Ulcerative Colitis Phase 3 UEG Congress
PRESS RELEASE

published on 09/23/2025 at 22:05, 2 months 11 days ago

Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting
Abivax announces presentation of late-breaking abstract for Obefazimod at 2025 United European Gastroenterology Meeting, showcasing potential as a new therapy for ulcerative colitis

Abivax Obefazimod Ulcerative Colitis Late-breaking Abstract UEG Meeting
BRIEF

published on 09/16/2025 at 18:05, 2 months 18 days ago

ABIVAX: Distribution of Share Capital and Voting Rights

Euronext Paris Share Capital Voting Rights AMF Abivax
BRIEF

published on 09/16/2025 at 10:04, 2 months 19 days ago

JP Morgan Chase exceeds 5% threshold in ABIVAX

Capital Actions Abivax Threshold Crossing JP Morgan Chase
BRIEF

published on 09/12/2025 at 17:50, 2 months 22 days ago

Abivax Joins CAC Mid 60 and SBF 120 Indices

Euronext Paris Biotechnology Abivax SBF 120 CAC Mid 60
PRESS RELEASE

published on 09/12/2025 at 17:45, 2 months 22 days ago

Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review
Abivax to join CAC Mid 60 and SBF 120 Indices on Euronext Paris following annual review, enhancing visibility and investor base

Euronext Paris Abivax SBF 120 Index Inclusion CAC Mid 60

Accesswire

Published on 12/05/2025 at 02:35, 7 hours 56 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 8 hours 1 minute ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 9 hours 31 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 11 hours 26 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 31 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 10:15, 16 minutes ago

Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 50 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 1 hour 1 minute ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 1 hour 25 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 1 hour 30 minutes ago

Original-Research: DEMIRE AG (von NuWays AG): BUY

Les Echos

Published on 12/05/2025 at 08:45, 1 hour 46 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 16 hours 31 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 16 hours 46 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 16 hours 47 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 3 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE